Keywords: Hikma, Egyptian Company for Pharmaceutical & Chemical Industries, M&A, MENA region

Hikma to buy Egyptian pharma company for around $20 million

Article | 10 January 2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire the Egyptian Company for Pharmaceuticals & Chemical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in